GHRSSMALL

GH Research PLC

HealthcareBiotechnology
$26.89
$0.01(+2.75%)
52W$11.32
$28.94
Updated Jul 8, 02:00 AM
RSI60
RS Rating94/99
Beta1.53
Volatility77%
F-Score3/9
Mkt Cap$1.8B
STAGE 2 UPTREND

Price Action

5Y Daily
50 DMA150 DMA200 DMA

Technical Summary

STAGE 2 UPTREND

GH Research PLC is in a confirmed Stage 2 uptrend, with price holding above all major moving averages and trend structure remaining intact. Relative strength is leading (RS Rating: 94), indicating clear outperformance against the broad market. Earnings contraction of 63% provides fundamental context to the price action. Investors should exercise caution due to high volatility (77% annualized), which requires wider risk management.

Relative Strength
94
out of 99
Market Leader
Trend Score
4/4
Minervini Criteria
STAGE 2 UPTREND
Risk (Beta)
1.53
vs S&P 500
HIGH BETA
52W Position
88%
from 52W low
Near High
Trend & Momentum Analysis

Trend Template (Minervini)

STAGE 2 UPTREND4/4 Criteria Met
CriterionValueStatus
Price > 50 SMA$22.59
50 SMA > 100 SMA$19.11
100 SMA > 150 SMA$17.65
150 SMA > 200 SMA$16.67

Price vs Moving Averages

PeriodValueSpreadSignal
20 SMA$23.63+13.79%ABOVE
50 SMA$22.59+19.03%ABOVE
100 SMA$19.11+40.72%ABOVE
150 SMA$17.65+52.34%ABOVE
200 SMA$16.67+61.34%ABOVE

Price Performance

1D+2.8%
1W+0.0%
1M+33.6%
3M+83.2%
6M+49.8%
YTD+103.1%
1Y+79.1%
3Y+28.4%
52-Week Trading Range88% from low
$26.89
52W Low$11.32
52W High$28.94

Technical Indicators

RSI (14)BULLISH
60.3
305070
Setup ScoreCOOL
5/10
Base depth: 51.2%

Risk Profile

Beta
1.53
52W Vol
77%
ATR
$1.65
Max DD (1Y)
-39%

Volume Analysis

Today
151.1K
50D Avg
217.2K
Vol Ratio
0.70x
Liquidity
MODERATE

Earnings Momentum

Q2'25+25%
$-0.15
Q3'25
$-0.23
Q4'25-35%
$-0.23
Q1'26-63%
$-0.31
Fundamentals & Growth

Growth Trends

Compounded Sales Growth

10 Years:
5 Years:
3 Years:
TTM:

Compounded Profit Growth

10 Years:
5 Years:
3 Years:
TTM:-16.46%

Stock Price CAGR

10 Years:+3.40%
5 Years:+6.00%
3 Years:+28.41%
1 Year:+79.15%

Return on Equity

10Y Avg:-23.3%
5Y Avg:-14.2%
3Y Avg:-18.6%
Last Year:-19.8%

Key Metrics

Market Cap$1.8B
Gross Margin
Net Margin
Piotroski F-Score3/9

Frequently Asked Questions

Is GHRS in an uptrend right now?

GHRS has a trend score of 4/4 based on Minervini's Stage Analysis. Yes, GHRS is in a Stage 2 uptrend with price above all major moving averages (50, 100, 150, 200 SMA) properly stacked.

Is GHRS overbought or oversold?

GHRS's RSI (14) is 60. The stock is in neutral territory, neither overbought nor oversold.

Is GHRS outperforming the market?

GHRS has a Relative Strength (RS) Rating of 94 out of 99. Yes, GHRS is a market leader, outperforming 94% of all stocks over the past 12 months.

Where is GHRS in its 52-week range?

GHRS is trading at $26.89, which is 93% of its 52-week high ($28.94) and 88% above its 52-week low ($11.32).

How volatile is GHRS?

GHRS has a Beta of 1.53 and 52-week volatility of 77%. It's more volatile than the S&P 500 - expect bigger swings.

Disclaimer: Data is for informational purposes only. May be delayed or contain errors. Past performance does not guarantee future results. This is not financial advice. Always conduct your own research and consult professionals before making investment decisions.